Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)

NCT01815632 is registered in ClinicalTrials.gov with North Bristol NHS Trust as lead sponsor.

NCT NCT01815632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01815632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)
Lead sponsor
North Bristol NHS Trust
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2014
Completion date
October 31, 2019
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

progressive multiple sclerosis